175 related articles for article (PubMed ID: 24474244)
1. Peritoneal malignant mesothelioma metastatic to supraclavicular lymph nodes.
Zannella S; Testi MA; Cattoretti G; Pelosi G; Zucchini N
Int J Surg Pathol; 2014 Sep; 22(6):552-4. PubMed ID: 24474244
[TBL] [Abstract][Full Text] [Related]
2. p16/CDKN2A FISH in Differentiation of Diffuse Malignant Peritoneal Mesothelioma From Mesothelial Hyperplasia and Epithelial Ovarian Cancer.
Ito T; Hamasaki M; Matsumoto S; Hiroshima K; Tsujimura T; Kawai T; Shimao Y; Marutsuka K; Moriguchi S; Maruyama R; Miyamoto S; Nabeshima K
Am J Clin Pathol; 2015 Jun; 143(6):830-8. PubMed ID: 25972325
[TBL] [Abstract][Full Text] [Related]
3. [Malignant peritoneal mesothelioma in a child. Diagnostic difficulties in a locally "non tumoral" form, revealed by cervical lymph node metastasis].
Bellocq JP; Chenard-Neu MP; Marcellin L; Lassabe-Roth C; Lutz P; Clavert JM; Batzenschlager A
Arch Anat Cytol Pathol; 1989; 37(5-6):240-7. PubMed ID: 2690755
[TBL] [Abstract][Full Text] [Related]
4. p16 FISH deletion in surface epithelial mesothelial proliferations is predictive of underlying invasive mesothelioma.
Hwang H; Tse C; Rodriguez S; Gown A; Churg A
Am J Surg Pathol; 2014 May; 38(5):681-8. PubMed ID: 24503757
[TBL] [Abstract][Full Text] [Related]
5. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
Illei PB; Ladanyi M; Rusch VW; Zakowski MF
Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
[TBL] [Abstract][Full Text] [Related]
6. 9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
Takeda M; Kasai T; Enomoto Y; Takano M; Morita K; Kadota E; Nonomura A
Pathol Int; 2010 May; 60(5):395-9. PubMed ID: 20518890
[TBL] [Abstract][Full Text] [Related]
7. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases.
Sussman J; Rosai J
Am J Surg Pathol; 1990 Sep; 14(9):819-28. PubMed ID: 2389813
[TBL] [Abstract][Full Text] [Related]
8. Metastatic appendiceal mucinous adenocarcinoma to well-differentiated diffuse mesothelioma of the peritoneal cavity: a mimicker of florid mesothelial hyperplasia in association with neoplasms.
Tran TA; Holloway RW; Finkler NJ
Int J Gynecol Pathol; 2008 Oct; 27(4):526-30. PubMed ID: 18753969
[TBL] [Abstract][Full Text] [Related]
9. Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology.
Matsumoto S; Nabeshima K; Kamei T; Hiroshima K; Kawahara K; Hata S; Marukawa K; Matsuno Y; Taguchi K; Tsujimura T
Cancer Cytopathol; 2013 Aug; 121(8):415-22. PubMed ID: 23450849
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas.
Chiosea S; Krasinskas A; Cagle PT; Mitchell KA; Zander DS; Dacic S
Mod Pathol; 2008 Jun; 21(6):742-7. PubMed ID: 18327208
[TBL] [Abstract][Full Text] [Related]
11. [Detection of p16 by fluorescence in-situ hybridization and immunohistochemistry in malignant mesothelioma].
Liu Y; Chen X; Ding N; Xu W; Yang H; Chen X
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):262-5. PubMed ID: 25975910
[TBL] [Abstract][Full Text] [Related]
12. FISH assay development for the detection of p16/CDKN2A deletion in malignant pleural mesothelioma.
Chung CT; Santos Gda C; Hwang DM; Ludkovski O; Pintilie M; Squire JA; Tsao MS
J Clin Pathol; 2010 Jul; 63(7):630-4. PubMed ID: 20591913
[TBL] [Abstract][Full Text] [Related]
13. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC
Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations.
Monaco SE; Shuai Y; Bansal M; Krasinskas AM; Dacic S
Am J Clin Pathol; 2011 Apr; 135(4):619-27. PubMed ID: 21411785
[TBL] [Abstract][Full Text] [Related]
15. Lymph node involvement in multicystic peritoneal mesothelioma.
Engohan-Aloghe C; Anaf V; Noël JC
Int J Gynecol Pathol; 2009 Nov; 28(6):594-7. PubMed ID: 19851213
[TBL] [Abstract][Full Text] [Related]
16. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases.
Lee S; Illei PB; Han JS; Epstein JI
Am J Surg Pathol; 2014 Jan; 38(1):54-9. PubMed ID: 24061516
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological characteristic of metastatic malignant mesothelioma initially diagnosed by lymph node biopsy.
Zhu XL; Gao LM; Li F; Liu WP; Zhang WY; Li GD; Zhang XH; Chen M; Liu XY; Zhao S
Pathol Res Pract; 2017 Jun; 213(6):598-605. PubMed ID: 28551387
[TBL] [Abstract][Full Text] [Related]
18. Malignant mesothelioma eight years after a diagnosis of atypical mesothelial hyperplasia.
Scurry J; Duggan MA
J Clin Pathol; 1999 Jul; 52(7):535-7. PubMed ID: 10605410
[TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma arising from a benign mediastinal mesothelial cyst.
Bierhoff E; Pfeifer U
Gen Diagn Pathol; 1996 Jun; 142(1):59-62. PubMed ID: 8793488
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
